Newsroom – Page 3

Home
-
Newsroom

~~Latest news~~

[Infography/Infographie] Covid19

# 5 KEY POINTS TO KNOW ABOUT ANTIBODIES # Available here #...

[Newsletter- 9] NEWS/INFOS

September 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19 <<...

[Press Alert] XENOTHERA obtains authorization from ANSM to start the clinical trial of XAV19, its anti Covid treatment

August 10, 2020. # Download our press release (english version) # Télécharger...

[Press Alert] XENOTHERA, Nantes University Hospital and the University of Nantes announce the signature of a consortium agreement within the framework of PSPC-COVID.

July 15, 2020. # Download our press release (english version) # Télécharger...

[Newsletter - 8] NEWS/INFOS

July 17,2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19 <<...

[Newsletter - 7] NEWS/INFOS

June 26, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

[Alerte actualité] Financement XENOTHERA

15 Juin 2020. Download the press release /Télécharger le communiqué

[Newsletter-6] NEWS/INFO

June 15, 2020. >> Breaking news / Edition spéciale << Download our...

[Newsletter-5] NEWS/INFOS

May 29, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

In the News/ A la une

Pays de la Loire (ma région) –Interview vidéo d’Odile Duvaux – Coronavirus...

[Newsletter -4] NEWS/INFOS

May 22, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

[Newsletter -3] NEWS/INFOS

May 15, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

[Newsletter -2] NEWS /INFOS

May 8, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

[Alerte actualité] Anticorps XAV19

30 avril 2020 Download the press release / Télécharger le communiqué

[Infographie] Traitement XAV19

Available here/Disponible ici

[Newsletter -1] NEWS / INFOS

May 1st, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

In the news / A la une

Journal des Entreprises – Coronavirus – XENOTHERA : « Nous prenons des risques entrepreneuriaux...

Covid-19 : Xenothera cherche les moyens de finaliser un traitement

[Article presse ] Par Frédéric Thual- La Tribune , à Nantes | 26/03/2020, 15:08 Avec...

COVID19 / XAV19 : Scientific and medical rationale

Français ci-dessous « We are convinced that our treatment will be efficient, for...

Interview d'Odile Duvaux, présidente de XENOTHERA dans Les Echos

[Article Presse] Par Emmanuel Guimard Publié le 20 mars 2020 à 17h14...

Le XAV19 de XENOTHERA, un traitement prometteur pour les cas graves de Coronavirus

[Communiqué ] Nantes , le 19 mars 2020 XENOTHERA pense détenir aujourd’hui...

XENOTHERA presents at Toulouse ONCOWEEK 2020

At ONCOWEEK 2020 that will take place in Toulouse on Feb. 3-5,...

The first patient has been injected 2 weeks ago

[ Communiqué ] Nantes, December 12th, 2019 XENOTHERA is pleased to give...

XENOTHERA receives approval for first in man Kidney Transplant Clinical Trial

Nantes, September 11th, 2019 – XENOTHERA announces it has received Czech Republic regulatory...